These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26954329)

  • 1. A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.
    Scott J; Underwood J; Garvey LJ; Mora-Peris B; Winston A
    Br J Radiol; 2016; 89(1060):20150979. PubMed ID: 26954329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Two Post-Processing Analysis Methods of Proton Magnetic Resonance Spectroscopy in Glioma Tumors.
    Saatchian E; Ehsani S; Montazerabadi A
    J Biomed Phys Eng; 2023 Feb; 13(1):39-44. PubMed ID: 36818014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study.
    Garvey L; Nelson M; Latch N; Erlwein OW; Allsop JM; Mitchell A; Kaye S; Watson V; Back D; Taylor-Robinson SD; Winston A
    J Antimicrob Chemother; 2012 Jan; 67(1):206-12. PubMed ID: 21987241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy.
    Vera JH; Garvey LJ; Allsop JM; Kaye S; McClure MO; Back D; Taylor-Robinson SD; Winston A
    HIV Clin Trials; 2012; 13(4):222-7. PubMed ID: 22849963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.
    Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ
    AIDS; 2016 Feb; 30(4):591-600. PubMed ID: 26825032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metabolite alterations demonstrated by proton magnetic resonance spectroscopy in diabetic patients with retinopathy.
    Tong J; Geng H; Zhang Z; Zhu X; Meng Q; Sun X; Zhang M; Qian R; Sun L; Liang Q
    Magn Reson Imaging; 2014 Oct; 32(8):1037-42. PubMed ID: 24985566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS.
    Keller MA; Venkatraman TN; Thomas MA; Deveikis A; Lopresti C; Hayes J; Berman N; Walot I; Ernst T; Chang L
    Neurology; 2006 Mar; 66(6):874-9. PubMed ID: 16567705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
    Banakar S; Thomas MA; Deveikis A; Watzl JQ; Hayes J; Keller MA
    J Magn Reson Imaging; 2008 Apr; 27(4):710-7. PubMed ID: 18383256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
    J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of reproducibility of single voxel spectroscopy and whole-brain magnetic resonance spectroscopy imaging at 3T.
    Zhang Y; Taub E; Salibi N; Uswatte G; Maudsley AA; Sheriff S; Womble B; Mark VW; Knight DC
    NMR Biomed; 2018 Apr; 31(4):e3898. PubMed ID: 29436038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.
    Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA;
    PLoS One; 2015; 10(2):e0118608. PubMed ID: 25723494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early glial activation precedes neurodegeneration in the cerebral cortex after SIV infection: a 3D, multivoxel proton magnetic resonance spectroscopy study.
    Wu WE; Babb JS; Tal A; Kirov II; George AE; Ratai EM; Gonzalez RG; Gonen O
    HIV Med; 2015 Jul; 16(6):381-7. PubMed ID: 25689120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.